Whole-brain multimodal neuroimaging model using serotonin receptor maps explains non-linear functional effects of LSD
This neuroimaging model (2018) of the whole brain (under LSD influence) offers causal (and non-linear) mechanisms linking neuromodulation and neuronal activity.
Authors
- Gitte Knudsen
- Robin Carhart-Harris
- Morten Kringelbach
Published
Abstract
Understanding the underlying mechanisms of the human brain in health and disease will require models with necessary and sufficient details to explain how function emerges from the underlying anatomy and is shaped by neuromodulation. Here, we provide such a detailed causal explanation using a whole-brain model integrating multimodal imaging in healthy human participants undergoing manipulation of the serotonin system. Specifically, we combined anatomical data from diffusion magnetic resonance imaging (dMRI) and functional magnetic resonance imaging (fMRI) with neurotransmitter data obtained with positron emission tomography (PET) of the detailed serotonin 2A receptor (5-HT2AR) density map. This allowed us to model the resting state (with and without concurrent music listening) and mechanistically explain the functional effects of 5-HT2AR stimulation with lysergic acid diethylamide (LSD) on healthy participants. The whole-brain model used a dynamical mean-field quantitative description of populations of excitatory and inhibitory neurons as well as the associated synaptic dynamics, where the neuronal gain function of the model is modulated by the 5-HT2AR density. The model identified the causative mechanisms for the non-linear interactions between the neuronal and neurotransmitter system, which are uniquely linked to (1) the underlying anatomical connectivity, (2) the modulation by the specific brainwide distribution of neurotransmitter receptor density, and (3) the non-linear interactions between the two. Taking neuromodulatory activity into account when modeling global brain dynamics will lead to novel insights into human brain function in health and disease and opens exciting possibilities for drug discovery and design in neuropsychiatric disorders.
Research Summary of 'Whole-brain multimodal neuroimaging model using serotonin receptor maps explains non-linear functional effects of LSD'
Introduction
Human brain function emerges from large-scale, non-linear interactions among interconnected neuronal populations. The authors note that whole-brain models based on structural and functional connectivity (for example, neural mass and mean-field models) have advanced understanding of resting-state networks, but such models often omit the spatially heterogeneous influence of neuromodulatory systems. Serotonergic neuromodulation, in particular, acts via regionally varying receptor densities that can change the gain and dynamics of local circuits and so may be necessary to explain some global functional effects observed in pharmacological manipulations. This study set out to test whether integrating an empirically derived map of serotonin 2A receptor (5-HT2A R) density into a biophysically informed whole-brain model can mechanistically explain the functional effects of the 5-HT2A agonist LSD in healthy participants. The authors introduced a global gain-scaling parameter (sE) that scales regional neuronal gain according to PET-derived 5-HT2A densities, fitted the model to placebo data, and asked whether adjusting sE (while keeping the placebo-derived coupling parameter fixed) could reproduce LSD-induced changes in functional connectivity dynamics. The work aims to provide a causal, mechanistic link between anatomy, receptor distribution, and functional dynamics induced by serotonergic stimulation.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typeindividual
- Journal
- Compound
- Topics
- Authors
- APA Citation
Deco, G., Cruzat, J., Cabral, J., Knudsen, G. M., Carhart-Harris, R. L., Whybrow, P. C., Logothetis, N. K., & Kringelbach, M. L. (2018). Whole-brain multimodal neuroimaging model using serotonin receptor maps explains non-linear functional effects of LSD. Current Biology, 28(19), 3065-3074.e6. https://doi.org/10.1016/j.cub.2018.07.083
References (10)
Papers cited by this study that are also in Blossom
Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L. et al. · PNAS (2016)
Kaelen, M., Barrett, F. S., Roseman, L. et al. · Psychopharmacology (2015)
Halberstadt, A. L. · Behavioural Brain Research (2014)
Carhart-Harris, R. L., Nutt, D. J. · Journal of Psychopharmacology (2017)
Preller, K. H., Herdener, M., Pokorny, T. et al. · Current Biology (2017)
Carhart-Harris, R. L., Kaelen, M., Bolstridge, M. et al. · Psychological Medicine (2016)
Nichols, D. E. · Current Topics in Behavioral Neurosciences (2017)
Atasoy, S., Leor, R., Kaelen, M. et al. · Scientific Reports (2017)
Carhart-Harris, R. L., Roseman, L., Haijen, E. C. H. M. et al. · Journal of Psychopharmacology (2018)
Kaelen, M., Lorenz, R., Barrett, F. S. et al. · Biorxiv (2017)
Cited By (23)
Papers in Blossom that reference this study
Mäki-Marttunen, V. · Communications Biology (2026)
Mallaroni, P., Singleton, P., Mason, N. L. et al. · Molecular Psychiatry (2026)
Singleton, S. P., Timmermann, C., Luppi, A. I. et al. · Communications Biology (2025)
Piccinini, J. I., Perl, Y. S., Pallavicini, C. et al. · Communications Biology (2025)
Shinozuka, K., Jerotic, K., Mediano, P. A. M. et al. · Translational Psychiatry (2024)
Juliani, A., Chelu, V., Graesser, L. et al. · Biorxiv (2024)
Tolle, H. M., Farah, J. C., Mallaroni, P. et al. · Network Neuroscience (2024)
Vohryzek, J., Cabral, J., Lord, L. D. et al. · Brain Communications (2024)
Erritzoe, D., Timmermann, C., Godfrey, K. et al. · Nature Mental Health (2024)
Pizzi, S. D., Chiacchiaretta, P., Sestieri, C. et al. · Biological Psychiatry (2023)
Show all 23 papersShow fewer
Herzog, R., Mediano, P. A. M., Rosas, F. E. et al. · Scientific Reports (2023)
Ruffini, G., Damiani, G., Lozano-Soldevilla, D. et al. · PLOS ONE (2023)
Kwan, A. C., Olson, D. E., Preller, K. H. et al. · Nature Medicine (2022)
Singleton, S. P., Luppi, A. I., Carhart-Harris, R. L. et al. · Nature Communications (2022)
Stoliker, D., Egan, G. F., Friston, K. J. et al. · Pharmacological Reviews (2022)
Luppi, A. I., Hansen, J. Y., Adapa, R. et al. · Biorxiv (2022)
McCulloch, D. E-W., Knudsen, G. M., Barrett, F. S. et al. · Neuroscience and Biobehavioral Reviews (2022)
Vollenweider, F. X., Smallridge, J. W. · Pharmacopsychiatry (2022)
Burt, J. B., Preller, K. H., Demirtaş, M. et al. · eLife (2021)
Pallavicini, C., Cavanna, F., Zamberlan, F. et al. · Journal of Psychopharmacology (2021)
Luppi, A. I., Carhart-Harris, R. L., Roseman, L. et al. · NeuroImage (2021)
Barnett, L., Muthukumaraswamy, S., Carhart-Harris, R. L. · NeuroImage (2020)
Dipasquale, O., Selvaggi, P., Veronese, M. et al. · NeuroImage (2019)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.